Sansure Biotech Partners with UBC to Manufacture in Indonesia
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has entered into a local manufacturing...
HutchMed Shifts Focus to Late-Stage Pipeline for Regulatory Approvals
Hutchison China Meditech (HutchMed; NASDAQ: HCM, HKG: 0013) has announced a strategic shift to focus...
Harbour BioMed and WuXi Biologics Announce Strategic Collaboration
Harbour BioMed (HKG: 2142), a global biotechnology company with operations in the United States, the...
Hengrui’s Pyrotinib Granted Priority Review for HER2-Positive Breast Cancer
The Center for Drug Evaluation (CDE) website has announced that China-based Hengrui Pharmaceuticals’ (SHA: 600276)...
CDE Issues Guidelines for Bispecific Antibody Antitumor Drug Development
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Research and...
AstraZeneca to Launch Soliris in Hangzhou After Regulatory Approval
UK-based pharmaceutical giant AstraZeneca Plc (AZ, NASDAQ: AZN) has revealed plans to sell Soliris (eculizumab)...
Akeso Biopharma’s AK112 Receives Two New Breakthrough Therapy Designations
The Center for Drug Evaluation (CDE) website indicates that China-based Akeso Biopharma (HKG: 9926) has...
CStone Launches Patient Assistance Program for IDH1 Inhibitor Tibsovo
CStone Pharmaceuticals (HKG: 2616) has announced the launch of a patient assistance scheme to support...
HutchMed Announces Initial Results from FRUTIGA Phase III Study
China-based Hutchison China Meditech (HutchMed; NASDAQ: HCM, HKG: 0013) has announced the initial results from...
BRL Medicine Raises RMB 200M in Series B Financing for CGT Development
BRL Medicine Inc., a cell and gene therapy (CGT) developer based in Shanghai, has reportedly...
Peijia Medical Enrolls First Patient in HighLife TSMVR Study
China’s Peijia Medical Limited (HKG: 9996) has announced the enrollment of the first patient and...
Acotec Scientific Secures FDA 510(k) Approval for Vericor Catheter
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received a 510(k)...
CStone Pharmaceuticals Suspends Operations at Suzhou Plant to Cut Costs
CStone Pharmaceuticals (HKG: 2616) has decided to suspend manufacturing operations at its Suzhou industrialization plant,...
Daxiang Biotech Raises RMB 100M in Pre-Series B Financing for Organoid-on-a-Chip
Beijing-based Daxiang Biotech Co., Ltd., a leading domestic company in the organoid-on-a-chip field, has reportedly...
Harbin Gloria Pharmaceuticals Faces Change in Control Amid Bankruptcy
China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) has disclosed that its controlling shareholder, Harbin...
HitGen Partners with Daewoong Pharmaceutical for Drug Discovery
China-based HitGen Inc. (SHA: 688222) has announced a research collaboration agreement with South Korea’s Daewoong...
AstraZeneca and CICC Capital Launch RMB 3 Billion Fund in Hangzhou
The joint venture (JV) between UK pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) and China’s CICC...
Henlius Biotech’s BRAF V600E Inhibitor HLX208 Approved for Clinical Study in China
China-based Shanghai Henlius Biotech (HKG: 2696) has announced that the National Medical Products Administration (NMPA)...
China Updates Hypertension Guidelines, Lowers Diagnostic Threshold
The National Center for Cardiovascular Diseases, the Chinese Medical Doctor Association (CMDA), and other organizations...
AstraZeneca Reports 19% YOY Revenue Growth in Q3 2022
UK-based pharmaceutical giant AstraZeneca Plc (AZ, NASDAQ: AZN) released its Q3 2022 earnings report, showing...